BioDiem Ltd - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDiem Ltd. (BioDiem) is an Australian biotechnology company based in Melbourne, with a focus on developing and commercializing vaccines and infectious disease therapies. The company develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. It receives revenues from vaccine licenses in India and China.

BioDiem Ltd Key Recent Developments

Dec 05, 2013: BioDiem Announces Publication of Research in Journal of Virology
Oct 28, 2013: BioDiem Announces Confirmation of Delisting from ASX
Oct 25, 2013: BioDiem Announces Change of Principal Place of Business and Registered Office
Oct 24, 2013: China presentation of BioDiem’s liver treatment technology
Aug 30, 2013: BioDiem Reports Proposed Delisting from ASX

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

BioDiem Ltd - Financial and Strategic SWOT Analysis Review
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
BioDiem Ltd - Key Facts 5
BioDiem Ltd - Key Employees 6
BioDiem Ltd - Key Employee Biographies 7
BioDiem Ltd - Key Operational Employees 8
BioDiem Ltd - Major Products and Services 9
BioDiem Ltd - Pharmaceutical Pipeline Products Data 10
BioDiem Ltd, Pipeline Products by Therapy Area 10
BioDiem Ltd, Pipeline Products by Development Phase 11
BioDiem Ltd - History 13
BioDiem Ltd - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 16
BioDiem Ltd - Business Description 16
BioDiem Ltd - SWOT Analysis 17
SWOT Analysis - Overview 17
BioDiem Ltd - Strengths 17
Strength - LAIV Technology 17
Strength - Strong Research and Development Capabilities 17
Strength - Global Partnering/Commercialization Network 17
BioDiem Ltd - Weaknesses 17
Weakness - Negative Operating Margin 17
Weakness - Limited Liquidity Position 17
BioDiem Ltd - Opportunities 18
Opportunity - Product Pipeline 18
Opportunity - Potential Market 18
Opportunity - Changing Demographics 18
BioDiem Ltd - Threats 18
Threat - Competition 18
Threat - Uncertain RandD Outcomes 18
BioDiem Ltd - Key Competitors 19
Section 3 - Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 - Company's Lifesciences Financial Deals and Alliances 25
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26
BioDiem Ltd, Recent Deals Summary 27
Section 5 - Company's Recent Developments 28
BioDiem Ltd, Recent Developments 28
Dec 05, 2013: BioDiem Announces Publication of Research in Journal of Virology 28
Oct 28, 2013: BioDiem Announces Confirmation of Delisting from ASX 28
Oct 25, 2013: BioDiem Announces Change of Principal Place of Business and Registered Office 28
Oct 24, 2013: China presentation of BioDiem's liver treatment technology 29
Aug 30, 2013: BioDiem Reports Proposed Delisting from ASX 29
Jul 22, 2013: Proof of Principle shown in liver disease vaccine program 30
Section 6 - Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35



List of Tables

BioDiem Ltd, Key Facts 5
BioDiem Ltd, Key Employees 6
BioDiem Ltd, Key Employee Biographies 7
BioDiem Ltd, Key Operational Employees 8
BioDiem Ltd, Major Products and Services 9
BioDiem Ltd, Number of Pipeline Products by Therapy Area 10
BioDiem Ltd, Number of Pipeline Products by Development Stage 11
BioDiem Ltd, Pipeline Products By Therapy Area and Development Phase 12
BioDiem Ltd, History 13
BioDiem Ltd, Subsidiaries 15
BioDiem Ltd, Key Competitors 19
BioDiem Ltd, Ratios based on current share price 20
BioDiem Ltd, Annual Ratios 20
BioDiem Ltd, Interim Ratios 23
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26
BioDiem Ltd, Recent Deals Summary 27
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34



List of Figures

BioDiem Ltd, Pipeline Products by Therapy Area 10
BioDiem Ltd, Pipeline Products by Development Phase 11
BioDiem Ltd, Performance Chart (2009 - 2013) 22
BioDiem Ltd, Ratio Charts 24
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
BioDiem Ltd, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 26

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.